Dominican company based in Santo Domingo · We only ship within the Dominican Republic · No international shippingDominican Republic only · No international shipping
ES Home Catalog Education COAs Calculator Founder
CJC-1295 without DAC
Renova Verification
  • ✓≥99% purity by HPLC + mass spectrometry
  • ✓Independent Janoshik 3rd-party analysis
  • ✓−20°C lyophilized · 2–8°C reconstituted
🧪 View COA →
Home › Products › Growth Hormone › CJC-1295 without DAC
← Back to catalog Growth HormoneComing Soon

CJC-1295 without DAC (5 mg)

GHRHMod GRFPulsatile
$120 USD5 mg/vial
🧪 Bacteriostatic water — needed to reconstitute the lyophilized vial
💰 Buy by volume
3+ of one
Save 15%
5+ of one
Save 25%
★ Wholesale
10+ of one
Save 40%
🔀 Mix & Match · across different products: 3+ items 10% · 5+ 15% · 7+ 20%
The best discount per product is applied automatically at checkout (they don't stack). Excludes bacteriostatic water; Retatrutide and Tirzepatide only get same-product volume. Can't be combined with promo codes.
🧪 COA❄️ Cold chain🛡️ Replacement guarantee🔒 Secure payment📦 Nationwide shipping🇺🇸 cGMP · ISO 9001 guidelines · COA

Modified GRF(1-29) — short-acting GHRH that preserves the natural pulsatile rhythm of growth hormone.

  • Mechanism: Mod GRF (1-29), short-acting GHRH analog; preserves the natural GH pulse. GHRH receptor known.
  • Evidence: Mostly preclinical; limited human efficacy data.
  • In context: GH/IGF-1 pro-growth (tumor caution).

Not in stock yet. Message us on WhatsApp and we'll let you know as soon as it arrives.

Research range · SC
100 mcg per application · 1–3×/day
🔴 Research convention · ~30 min half-life

Ranges cited in research literature. Not a usage recommendation. For research use only.

📋 Technical datasheet · Compound specifications
CompoundCJC-1295 without DAC
Origin🇺🇸 From US-based suppliers that follow strict cGMP & ISO 9001 guidelines
FormLyophilized in sterile vial (or pre-mixed solution depending on SKU)
Molecular formulaC152H252N44O42
Molecular weight3367.97 g/mol
Purity≥99% by HPLC + mass spectrometry (Janoshik Analytical)
StorageLyophilized: −20°C to −80°C, dry, dark · Reconstituted: 2–8°C · stability varies by peptide (see the reconstitution guide and the product COA)
Recommended solventBacteriostatic water (0.9% benzyl alcohol) or 0.9% saline
Cold chain2–8°C in transit · controlled thermal packaging
UseResearch Use Only (RUO). Not intended for human or veterinary use.

Typical values for this compound category. For product-specific data, see the corresponding COA at /en/coa/.

This product is exclusively for research purposes. Not intended for human use, consumption, or therapeutic applications. For laboratory use only under qualified supervision.

CJC-1295 without DAC: research profile

CJC-1295 without DAC, technically named Modified GRF (1-29) or tetrasubstituted GRF(1-29), is an analog of the first 29 amino acids of human GHRH — the portion sufficient to activate its receptor — with four changes from the native sequence: D-alanine at position 2 (resists DPP-4), glutamine at 8 (prevents deamidation), alanine at 15 (improves affinity) and leucine at 27 (replaces an oxidizable methionine). It is the same sequence as CJC-1295 with DAC, minus the albumin-binding complex.

Without that complex its half-life is about 30 minutes: long enough to trigger a broad, clean GH pulse through the pituitary GHRH receptor, and short enough for secretion to return to its baseline pattern afterward. In research it is valued precisely for that: it allows studying the somatotroph response pulse by pulse, and combined with a ghrelin-receptor agonist it reproduces the GHRH + GHRP synergy described in humans.

There are no clinical efficacy trials of Mod GRF 1-29 as such; human data correspond to the pharmacology of GHRH analogs in general and to single-dose studies. It shares the whole class's considerations on GH and IGF-1 (glucose, fluid retention, theoretical caution in tumors) and appears on the World Anti-Doping Agency list. Renova distributes it for research only, individually and as a component of the blend with ipamorelin.

CJC-1295 without DAC technical data

ClassShort-acting GHRH(1-29) analog (Modified GRF 1-29)
SequenceGHRH(1-29)-NH2 with D-Ala2, Gln8, Ala15, Leu27 (29 aa)
SubstitutionsD-Ala2: DPP-4 resistance · Gln8: prevents deamidation · Ala15: affinity · Leu27: prevents oxidation
ReceptorGHRH receptor (anterior pituitary)
Half-life≈ 30 minutes
Difference from DACSame sequence without the albumin-binding group; short pulses instead of a days-long elevation
Regulatory statusNot approved; WADA list (S2)
Renova presentations5 mg vial; component of the CJC-1295 / Ipamorelin blend

Questions about CJC-1295 without DAC

Why is it called “modified” if it is GHRH?

Because four substitutions were made on the first 29 amino acids of natural GHRH to make it more stable: a D-alanine that blocks the DPP-4 enzyme, a glutamine that prevents deamidation, an alanine that improves receptor binding and a leucine that replaces an oxidation-prone methionine. The active sequence is the same; the molecule lasts longer.

What is the real difference between CJC-1295 without DAC and sermorelin?

Both are GHRH(1-29). Sermorelin has the native sequence and a half-life of 10–20 minutes; Mod GRF 1-29 carries the four substitutions and lasts about 30 minutes. Sermorelin was approved as a medicine (Geref); Mod GRF 1-29 was never developed clinically.

Is it better with DAC or without?

They are different tools. Without DAC it produces short GH pulses resembling the physiological pattern; with DAC it raises GH and IGF-1 continuously for almost a week. The choice depends on what is being studied; our CJC-1295 + Ipamorelin stack guide explains both cases.

What is CJC-1295 without DAC usually combined with?

With ipamorelin, a selective ghrelin-receptor agonist, because the two classes potentiate each other in GH release. Renova offers that combination already co-lyophilized (CJC-1295 / Ipamorelin) or the separate vials to adjust the ratio.

Related reading: CJC-1295 + Ipamorelin: The Most-Studied GH Stack

Informational content based on published scientific literature; it is not a recommendation for use or medical advice. Product strictly for research use (RUO), not suitable for human or veterinary consumption.

Questions? Write us

Your Order

Your cart is empty